Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos ...

The FOXA1 protein is a potentially highly sensitive diagnostic marker for small cell carcinoma of the prostate and possibly other aggressive prostate cancer subtypes that are difficult to diagnose due ...

This morning, we're focusing on a health issue that impacts millions of men and their families every year. Prostate cancer. We speak with doctors and a patient about the symptoms and treatment options ...

Prostate cancer can be difficult to detect in its beginning stages — here's what to look out for Prostate cancer is one of the most common types of cancer in males. It starts in the prostate, a small ...

Fear can take over the moment prostate cancer progresses. These questions can help caregivers replace confusion with clarity, ...

Stage 3 prostate cancer is locally advanced, with tumors extending beyond the prostate but not metastasizing distantly. Diagnosis involves the TNM system, Gleason score, PSA tests, and imaging to ...

Doctors followed standard testing guidelines, which recommend discontinuing screenings for men over 70 years old. Should that change?

Prostate cancer is the second-most-common cancer in men after skin cancer, according to the American Cancer Society. But there’s good news: When caught early, prostate cancer is highly treatable. And ...

Aggressive prostate cancers often lose expression of traditional markers after treatment, making it hard to diagnose the tumor’s origin and complicating treatment decisions Researchers sought new ...